No, that is not how it happens.
I do respect your tenacity in your Due Diligence, but you must clarify your excellent DD with reasonable prognosis and not hyperbole's or blanket assumptions.
First and foremost, brokers do not inventory companies stock. Brokers bring together buyers and sellers of securities, but never take a position in companies stock to be exchanged or held.
Now on with the 50m added to the O/S that obviously came about after Dec 2016 and we know that the O/S were 605m and now is 650m and came after Dec. 2016.
I'm certain that the 50m shares that were added was to cement the folks that own the Florida Clinics and became a partnership or part of the management team. I have mentioned this in the past as how much of these transactions occur doing transitional periods with respect to R/M.
Now of course, this is just my hypothesis and it can only be verified in the next financial release, and the reason why 'the broker analogy' is incorrect, simply to the effect that would construe as an Equity financial package, which must be released in the public domain, which we didn't see.
So the increase of 50m will be in the next financial release and my guess will be what I stated above.
This will probably be in the way of Preferred, Warrants or some other mechanism, not to mention that whatever is laid out as to what is involved, it will probably be restricted until in most cases a year and then the rules for vested program sets in.
We also know that Mark is out of the picture according to Lawomen, who has repeatedly mentioned this and the PR from Weber also stated this with respect to the R/M.
Next week is going to be a good week.
Have a good day
varok
